Glaucoma Drainage Devices Industry Forecast: Key Players and Growth Analysis 2025-2030

Glaucoma Drainage Devices Market Projected to Expand at 10.56% CAGR Through 2030

The Global Glaucoma Drainage Devices Market size was valued at around USD 716 million in 2024 and is projected to reach USD 1,300 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.56% during the forecast period, i.e., 2025-30. Glaucoma drainage device’s demand is growing significantly globally due to an aging population who are more vulnerable to glaucoma and different eye issues. According to the World Health Organization, nearly 2.1 billion individuals will be over 60 by 2050 globally, substantially increasing the demand for contemporary glaucoma remedies. The accessibility of glaucoma treatment is also being improved by government projects and repayment guidelines. For instance, in the United States Medicare covers most glaucoma-related procedures, which lowers the value for sufferers.

Markntel Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report

Strategic Takeaways from the Report:

Market Sizing and Forecasting
Regulatory and Policy Influence
Competitive Trends and M&A Activity
Innovation Drivers and Disruptive Technologies
Investment Hotspots and Emerging Niches
Geographical Dynamics and Trade Flows

Glaucoma Drainage Devices Market Segment Overview & Classification

This market is categorized to offer targeted insights across various operational and consumer-related verticals.

Segment List:

By Product Type

Conventional Glaucoma Drainage Devices- Market Size & Forecast 2020-2030, USD Million
- Valveless Glaucoma Drainage Devices- Market Size & Forecast 2020-2030, USD Million
- Valved Glaucoma Drainage Devices- Market Size & Forecast 2020-2030, USD Million
Minimally Invasive Glaucoma Surgery (MIGS) Devices- Market Size & Forecast 2020-2030, USD Million
- Schlemm’s Canal MIGS Devices- Market Size & Forecast 2020-2030, USD Million
- Suprachoroidal MIGS Devices- Market Size & Forecast 2020-2030, USD Million
- Subconjunctival MIGS Devices- Market Size & Forecast 2020-2030, USD Million

Approximately 65% of the global market for glaucoma drainage devices is dominated by gadgets used in minimally invasive glaucoma surgery. Given their lower risk profile, quicker recovery, and fewer post-operative complications than traditional drainage implants, MIGS devices have become more popular. The OMNI Surgical device, Hydrus microstent, and iStent Inject are some of the devices that have become widely used, especially for patients with moderate-to-mild open-angle glaucoma. In the future years, it is anticipated that ongoing trends in micro-stent technologies and bioengineered substances will further solidify MIGS devices' dominance.

By End User

Hospitals- Market Size & Forecast 2020-2030, USD Million
Specialty Clinics- Market Size & Forecast 2020-2030, USD Million
Others- Market Size & Forecast 2020-2030, USD Million

About 55% of the global market for glaucoma drainage devices is held by the hospital segment. Because of their specialized gadget, sophisticated clinical infrastructure, and potential to carry out difficult surgical procedures, hospitals remain the primary end users for these advanced devices. The number of health center-based surgical procedures has accelerated because of the growing prevalence of glaucoma especially in older adults. Hospitals dominate this market because of the continuous improvements in glaucoma surgery methods and the incorporation of technology.

By Region

North America
South America
Europe
Middle East and Africa
Asia-Pacific.

The global market for glaucoma drainage devices is dominated by North America which accounts for 40% of the market. The region's high glaucoma prevalence particularly among the elderly population is the cause of this dominance. North America enjoys a high standard of medical care, established reimbursement practices, and an advanced healthcare infrastructure. The U.S. is a crucial market because of the growing use of sophisticated surgical techniques and government programs to increase access to healthcare.

These divisions help clarify demand patterns and expected shifts.

Market Opportunities

Development of Biodegradable & Smart Drainage Devices – There is a significant market for intelligent and biodegradable glaucoma drainage devices. Conventional implants are often ineffective as they can lead to chronic problems like infection or fibrosis, or require removal. Researchers are creating biodegradable implants to overcome these difficulties. These implants will eventually dissolve once intraocular pressure has stabilized, removing the need for further procedures.

Additionally, smart drainage devices that incorporate pressure-monitoring systems and microsensors are becoming more popular. These devices improve patient outcomes by automatically adjusting fluid drainage and enabling real-time tracking of IOP fluctuations. Patients with poorly managed intraocular pressure have a 30% increased risk of vision loss, underscoring the need for precise treatments. The future of glaucoma treatment is being driven by partnerships between Harvard Medical School and MIT that are speeding up innovation in self-regulating drainage implants.

Glaucoma Drainage Devices Market Competitive Snapshot from 2025-2030

The report highlights established and emerging players in the global Glaucoma Drainage Devices Market, evaluating their strengths, challenges, and potential for innovation.

Key Competitors Include:

Johnson & Johnson
AbbVie Inc.
Alcon Inc.
Glaukos Corporation
NovaEye Medical Limited
iSTAR Medical
Rheon-medical
New World Medical Inc.
Aurolab
Santen Pharmaceutical Co., Ltd.
Advanced Ophthalmic Innovations Pte Ltd.

Their activities include partnerships, product launches, and geographic expansions.

Glaucoma Drainage Devices Industry Prime Challenge

High Cost of Glaucoma Drainage Devices and Surgeries – One of the biggest obstacles in the market is the high expense of glaucoma drainage devices and related surgical procedures. Glaucoma drainage implants typically cost between USD 1,000 and USD 2,000 per device, not including post-operative care and surgery, which can raise overall costs to over USD 11,000 per procedure. Many patients find treatment unaffordable as a result, especially in low-middle-income countries where financial limitations prevent glaucoma cases from being diagnosed.

Advanced minimally invasive glaucoma surgery techniques like those utilizing Xen Gel Stent or Hydrus Microstent also come with higher operating costs because they call for specific surgical skills. Patient access is further limited by gaps in reimbursement and limited insurance coverage. The World Glaucoma Association reports that up to 22% of patients who have untreated glaucoma become blind within five years.

Frequently Asked Questions (FAQs):

What industries are most impacted by this market?
How is technology reshaping operations and offerings?
Which competitors dominate the landscape?
What risks could disrupt market expansion?
How should businesses respond to demand fluctuations?

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Other Report:

Note: If you need additional information not included in the report, we can customize it to suit your requirements. https://www.marknteladvisors.com/query/request-customization/glaucoma-drainage-devices-market.html

Why Trust MarkNtel Advisors?

In-depth primary and secondary data validation
Focused on practical insights, not just raw numbers
Designed to support business strategy, not just reporting
Strong industry connections and real-time data flow
Transparent methodology and reliable sourcing

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India